Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Photothermal hydrogels (PTHs) are considered next‐generation biomaterials as they offer remotely defined biophysical information of the extracellular milieu. PTHs allow precise and non‐genetic control for the regeneration of native tissues, which is the ultimate goal of tissue engineering (TE). Molecular and physical properties of PTHs, such as components, structural configurations, and mechanical characteristics, collectively serve as determinants for understanding the dynamic tissue response and clinical translation. PTHs have entered a period of fruition due to the development of numerous manufacturing technologies and polymeric matrices. Herein, this review comprehensively and meticulously elucidates the mechanisms of regenerative therapeutics underlying the design and fabrication of PTHs. Recent advances in the photothermal principles and various categories of photothermal agents (PTAs) have been extensively discussed. Vital components and structures of PTHs are summarized to enable efficacious and precise therapeutic energy delivery. Emerging applications of PTHs in TE are also demonstrated, which expand the strategies for the intrinsic regeneration of injured tissues. Then deliberate the structural and chemical engineering of PTHs to enhance prognosis while highlighting the challenges associated with clinical translation. In this review, we aim to provide guidance and prospects for exploration and innovation of PTHs in the field of TE.
Photothermal hydrogels (PTHs) are considered next‐generation biomaterials as they offer remotely defined biophysical information of the extracellular milieu. PTHs allow precise and non‐genetic control for the regeneration of native tissues, which is the ultimate goal of tissue engineering (TE). Molecular and physical properties of PTHs, such as components, structural configurations, and mechanical characteristics, collectively serve as determinants for understanding the dynamic tissue response and clinical translation. PTHs have entered a period of fruition due to the development of numerous manufacturing technologies and polymeric matrices. Herein, this review comprehensively and meticulously elucidates the mechanisms of regenerative therapeutics underlying the design and fabrication of PTHs. Recent advances in the photothermal principles and various categories of photothermal agents (PTAs) have been extensively discussed. Vital components and structures of PTHs are summarized to enable efficacious and precise therapeutic energy delivery. Emerging applications of PTHs in TE are also demonstrated, which expand the strategies for the intrinsic regeneration of injured tissues. Then deliberate the structural and chemical engineering of PTHs to enhance prognosis while highlighting the challenges associated with clinical translation. In this review, we aim to provide guidance and prospects for exploration and innovation of PTHs in the field of TE.
Critical limb ischemia (CLI) presents a significant clinical challenge, leading to tissue ischemia and potentially resulting in limb necrosis or amputation. Cell‐based regenerative therapies offer promise for improving outcomes in CLI, but their effectiveness is often limited by poor cell survival and engraftment. This study hypothesized that a thermo‐responsive polymer, poly(polyethylene glycol citrate‐co‐N‐isopropylacrylamide) (PPCN), combined with pro‐survival bioactive peptides, can create a protective microenvironment to improve endothelial cell survival and function after their delivery. Through in vitro and in vivo experiments, laminin‐derived peptide A5G81 and vascular endothelial growth factor (VEGF)‐derived peptide QK are identified as effective in promoting endothelial cell spreading, proliferation, and prolonged survival. PPCN's viscoelastic properties protected against shear stress during injection, while the peptides supported endothelial cell behavior through distinct molecular pathways. Importantly, delivery of endothelial cells with PPCN‐A5G81 and PPCN‐QK in a murine hindlimb ischemia model resulted in significant improvements in limb perfusion, tissue preservation, and functional outcomes compared to controls. Additionally, this approach enhanced skeletal muscle remodeling following ischemic injury. This innovative biomaterial platform represents a versatile solution for addressing cell survival challenges and advancing regenerative therapies in CLI and other ischemic conditions.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.